US · Healthcare · Biotechnology
EPS came in at -0.03 against a street estimate of -0.01 — a miss of 200.0%.
Analysts rate Geron Corporation a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $3.62.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.64% |
| RA Capital Management, LLC | 6.66% |
| Soleus Capital Management, L.P. | 6.66% |
| State Street Corp | 5.58% |
| Citadel Advisors Llc | 4.52% |
| Vanguard Capital Management, LLC | 4.24% |
| Nantahala Capital Management, LLC | 3.81% |
| ClearBridge Advisors, LLC | 3.06% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 total revenue was $60,190, compared with $47,227 in the third quarter of 2025. • Third-quarter 2026 net income | 2026-11-04 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 RYTELO net product revenue was $60.1 million, up 5% from Q2 2026 and up from $47.2 million in Q3 2025. • RYTELO demand gr | 2026-11-04 |
| Company announcement · Q4 2026 HEADLINE NUMBERS • Geron Corporation filed an 8-K on October 28, 2026, reporting an update to the Phase 3 IMpactMF clinical trial. • The trial is ev | 2026-10-28 |
| Results announced · Q3 2026 GERON CORPORATION Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 RYTELO net product revenue: $57.5 million (11% increase vs Q1 2026) • | 2026-08-06 |
| Quarterly report · Q2 2026 GERON CORPORATION – FORM 10-Q SUMMARY Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Cash and marketable securities combined: $326.9 million (J | 2026-08-05 |
| Board / officer change · Q2 2026 GERON CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held May 20, 2026 (virtual format) • 4,500,000 new shares authorized u | 2026-05-27 |
| Quarterly report · Q1 2026 GERON CORPORATION – Q1 2026 SUMMARY HEADLINE NUMBERS • Product Revenue (Q1 2026): $51.8 million total revenues (product: $51.8M, royalties: $66K), u | 2026-05-06 |
| Proxy statement · Q2 2026 GERON CORPORATION PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect three directors to Class III Board positions (serving | 2026-04-07 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Geron Corporation — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.